Frontiers in Pharmacology | Respiratory Pharmacology

Review

Published on 10 Jan 2022

Efficacy and Safety of Bilastine in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis

in Respiratory Pharmacology

Aranjit Singh Randhawa
Norhayati Mohd Noor
Mohd Khairi Md Daud
Baharudin Abdullah

Frontiers in Pharmacology

doi 10.3389/fphar.2021.731201

52,706 views
18 citations

Mini Review

Published on 10 Jan 2022

Obesity and the Development of Lung Fibrosis

in Respiratory Pharmacology

Xia Guo
Christudas Sunil
Guoqing Qian

Frontiers in Pharmacology

doi 10.3389/fphar.2021.812166

10,640 views
26 citations

Review

Published on 05 Jan 2022

The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs

in Respiratory Pharmacology

Hao Shen
Nu Zhang
Yuqing Liu
Xuerong Yang
Yuanyuan He
Qi Li
Xiaoyan Shen
Yulian Zhu
Yong Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.805535

12,030 views
27 citations

Correction

Published on 05 Jan 2022

Corrigendum: The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook

in Respiratory Pharmacology

Mingyao Luo
Mingyuan Du
Chang Shu
Sheng Liu
Jiehua Li
Lei Zhang
Xin Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.822059

1,396 views

Original Research

Published on 04 Jan 2022

Iron-Dependent Mitochondrial Dysfunction Contributes to the Pathogenesis of Pulmonary Fibrosis

in Respiratory Pharmacology

Mai Takahashi
Kenji Mizumura
Yasuhiro Gon
Tetsuo Shimizu
Yutaka Kozu
Sotaro Shikano
Yuko Iida
Mari Hikichi
Shinichi Okamoto
Kota Tsuya

Frontiers in Pharmacology

doi 10.3389/fphar.2021.643980

7,446 views
32 citations

Original Research

Published on 03 Jan 2022

Elevated Serum Leptin Levels in Patients With Eosinophilic Chronic Rhinosinusitis

in Respiratory Pharmacology

Yoshimasa Imoto
Shigeharu Ueki
Yukinori Kato
Kanako Yoshida
Taiyo Morikawa
Yukihiro Kimura
Masanori Kidoguchi
Toshiki Tsutsumiuchi
Keisuke Koyama
Naoto Adachi

Frontiers in Pharmacology

doi 10.3389/fphar.2021.793607

3,775 views
9 citations

Original Research

Published on 24 Dec 2021

Latent Transforming Growth Factor-β Binding Protein-2 Regulates Lung Fibroblast-to-Myofibroblast Differentiation in Pulmonary Fibrosis via NF-κB Signaling

in Respiratory Pharmacology

Menglin Zou
Jingfeng Zou
Xingxing Hu
Weishuai Zheng
Mingyang Zhang
Zhenshun Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2021.788714

5,802 views
15 citations

Original Research

Published on 24 Dec 2021

Sanguinarine Reverses Pulmonary Vascular Remolding of Hypoxia-Induced PH via Survivin/HIF1α-Attenuating Kv Channels

in Respiratory Pharmacology

Fenling Fan
Yifan Zou
Yousen Wang
Peng Zhang
Xiaoyu Wang
Anthony M. Dart
Yuliang Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2021.768513

3,584 views
9 citations

Review

Published on 23 Dec 2021

Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern

in Respiratory Pharmacology

Khursheed Ul Islam
Thoraya Mohamed Elhassan A-Elgadir
Sarah Afaq
Tanveer Ahmad
Jawed Iqbal

Frontiers in Pharmacology

doi 10.3389/fphar.2021.778219

5,580 views
2 citations

Original Research

Published on 23 Dec 2021

Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19

in Respiratory Pharmacology

Wenjiang Zheng
Ting Wang
Peng Wu
Qian Yan
Chengxin Liu
Hui Wu
Shaofeng Zhan
Xiaohong Liu
Yong Jiang
Hongfa Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.718874

3,600 views
1 citation

Original Research

Published on 22 Dec 2021

Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline

in Respiratory Pharmacology

Alexandra Nagy
Tamas Nagy
Abigel Margit Kolonics-Farkas
Noemi Eszes
Krisztina Vincze
Eniko Barczi
Adam Domonkos Tarnoki
David Laszlo Tarnoki
György Nagy
Emese Kiss

Frontiers in Pharmacology

doi 10.3389/fphar.2021.778649

6,754 views
14 citations

Original Research

Published on 22 Dec 2021

Respiratory Adherence Care Enhancer Questionnaire: Identifying Self-Management Barriers of Inhalation Corticosteroids in Asthma

in Respiratory Pharmacology

Claire D. Visser
Jip M. Linthorst
Esther Kuipers
Jacob K. Sont
Joyca P. W. Lacroix
Henk-Jan Guchelaar
Martina Teichert

Frontiers in Pharmacology

doi 10.3389/fphar.2021.767092

5,077 views
1 citation

Original Research

Published on 20 Dec 2021

Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels

in Respiratory Pharmacology

Ruihua Cao
Tao Sun
Ruyi Xu
Jin Zheng
Hao Wang
Xiaona Wang
Yongyi Bai
Ping Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2021.764046

1,804 views
1 citation

Original Research

Published on 20 Dec 2021

Protective Effect of Fluorofenidone Against Acute Lung Injury Through Suppressing the MAPK/NF-κB Pathway

in Respiratory Pharmacology

Xin Lv
Tingting Yao
Rongling He
Yijun He
Mengyu Li
Yuanyuan Han
Yan Zhang
Lingzhi Long
Guoliang Jiang
Xiaoyun Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2021.772031

3,446 views
15 citations

Correction

Published on 15 Dec 2021

Corrigendum: Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension

in Respiratory Pharmacology

Yang-Yang He
Xin-Mei Xie
Hong-Da Zhang
Jue Ye
Selin Gencer
Emiel P. C. van der Vorst
Yvonne Döring
Christian Weber
Xiao-Bin Pang
Zhi-Cheng Jing

Frontiers in Pharmacology

doi 10.3389/fphar.2021.810178

1,734 views
1 citation

Original Research

Published on 14 Dec 2021

Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension

in Respiratory Pharmacology

Yang-Yang He
Xin-Mei Xie
Hong-Da Zhang
Jue Ye
Selin Gencer
Emiel P. C. van der Vorst
Yvonne Döring
Christian Weber
Xiao-Bin Pang
Zhi-Cheng Jing

Frontiers in Pharmacology

doi 10.3389/fphar.2021.753727

8,479 views
22 citations

Navigation group

Articles

Efficacy and Safety of Bilastine in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis

Obesity and the Development of Lung Fibrosis

The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs

Corrigendum: The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook

Iron-Dependent Mitochondrial Dysfunction Contributes to the Pathogenesis of Pulmonary Fibrosis

Elevated Serum Leptin Levels in Patients With Eosinophilic Chronic Rhinosinusitis

Latent Transforming Growth Factor-β Binding Protein-2 Regulates Lung Fibroblast-to-Myofibroblast Differentiation in Pulmonary Fibrosis via NF-κB Signaling

Sanguinarine Reverses Pulmonary Vascular Remolding of Hypoxia-Induced PH via Survivin/HIF1α-Attenuating Kv Channels

Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern

Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19

Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline

Respiratory Adherence Care Enhancer Questionnaire: Identifying Self-Management Barriers of Inhalation Corticosteroids in Asthma

Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels

Protective Effect of Fluorofenidone Against Acute Lung Injury Through Suppressing the MAPK/NF-κB Pathway

Corrigendum: Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension

Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension